Fred Craves
InvestorManaging Director at Bay City Capital
San Francisco, CA
FoundedDermiraTwist Bioscience
About
Fred Craves, PhD, founded Bay City Capital in 1997 and built it into a leading life science investment firm, backing nearly 100 companies. He has held senior roles including EVP of Schering Berlin, CEO of Berlex Biosciences, and founded Reliant Pharmaceuticals (sold to GlaxoSmithKline in 2007). He holds a BS in Biology from Georgetown and a PhD in Pharmacology and Toxicology from UCSF, and has been named to the Forbes Midas List.
Invests in
BiotechDigital Health
Investments
Board seats
IMIDomics Inc.KBP BiosciencesMadrigal PharmaceuticalsSynchronicity (formerly Reset Therapeutics)
Investor
DermiraIncyte PharmaceuticalsIon TorrentMedarexReliant PharmaceuticalsTwist Bioscience
Per the firm's website.
Colleagues at Bay City Capital
Carl Goldfischer
Advisor, MD at Bay City Capital
David Beier
Managing Director at Bay City Capital
Larry Clay
Professional Staff at Bay City Capital
Lionel Carnot
Advisor, MS, MBA at Bay City Capital
Manuel Lopez-Figueroa
Advisor, PhD at Bay City Capital
Matthew Kronmiller
Vice President at Bay City Capital
Susan Vuong
Professional Staff at Bay City Capital